Canadian Journal of Gastroenterology and Hepatology / 2018 / Article / Tab 4 / Research Article
Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD) Table 4 The differences in the fatty acid profile before and after the dietary intervention.
Fatty acid [ ] Before diet After diet p. value Mean SD Mean SD C10:0 capric acid 2.05 3.13 2.37 0.72 NS C14:0 myristic acid 2.18 2.15 2.35 0.99 NS C14:1 myristoleic acid 0.75 0.72 1.38 5.30 NS C15:0 pentadecanoate acid 0.29 0.32 0.27 0.24 NS C16:0 palmitic acid 35.81 11.22 34.98 11.17 p<0.055 C16:1 palmitoleic acid 1.04 0.69 0.60 0.63 p<0.05 C17:0 heptadecanoic acid 0.49 0.32 1.63 5.51 NS C17:1 heptadecanoic acid 0.54 0.64 0.58 0.63 NS C18:0 stearic acid 30.53 10.28 28.90 9.86 p<0.05 C18:1 n9 oleic acid 7.22 6.63 5.95 5.13 p<0,05 C18:1 n7 vaccenic acid 0.71 0.62 0.59 0.56 NS C18:2 n6 linoleic acid (LA) 4.98 3.50 4.27 3.67 p<0.05 C18:3 n6 γ - linolenic acid (GLA) 0.22 0.31 0.32 0.59 NS C18:3 n3 α - linolenic acid (ALA) 0.70 0.98 0.96 0.76 NS C20:0 arachidic acid 0.35 0.37 0.49 0.70 NS C20:1 eicosanoic acid 0.35 0.27 0.41 0.38 NS C20:3 n6 eicosatrienoic acid 0.94 0.64 0.91 0.72 NS C20:4 n6 arachidonic acid (AA) 6.22 6.67 5.10 5.77 p<0.05 C20:5 n3 eicosapentaenoic acid (EPA) 0.57 0.53 0.77 0.68 p<0.055 C23:0 tricosanoic acid 0.27 0.51 0.25 0.50 NS C22:4 n6 docosatetraenoic acid 1.14 1.22 1.52 1.22 NS C22:5 n3 docosapentaenoic acid 1.20 1.21 1.94 1.36 NS C22:6 n3 docosahexaenoic acid (DHA) 1.34 2.35 3.34 2.36 p<0.05